Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1960 4
1975 2
1976 4
1978 1
1979 2
1980 1
1981 3
1982 4
1983 2
1984 6
1985 1
1986 1
1987 5
1988 4
1989 9
1990 6
1991 7
1992 10
1993 13
1994 12
1995 16
1996 18
1997 25
1998 35
1999 60
2000 54
2001 67
2002 76
2003 85
2004 94
2005 112
2006 160
2007 182
2008 173
2009 179
2010 259
2011 316
2012 302
2013 370
2014 346
2015 353
2016 411
2017 353
2018 390
2019 406
2020 388
2021 420
2022 405
2023 342
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

5,691 results

Results by year

Filters applied: . Clear all
Page 1
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. Dumortier G, et al. Pharm Res. 2006 Dec;23(12):2709-28. doi: 10.1007/s11095-006-9104-4. Epub 2006 Nov 11. Pharm Res. 2006. PMID: 17096184 Review.
Combination with other excipients like Poloxamer 188 or mucoadhesive polymers promotes Poloxamer 407 action by optimising sol-gel transition temperature or increasing bioadhesive properties. Inclusion of liposomes or micro(nano)particles in Poloxamer 407 form …
Combination with other excipients like Poloxamer 188 or mucoadhesive polymers promotes Poloxamer 407 action by optimising sol- …
Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?
Bollenbach L, Buske J, Mäder K, Garidel P. Bollenbach L, et al. Int J Pharm. 2022 May 25;620:121706. doi: 10.1016/j.ijpharm.2022.121706. Epub 2022 Apr 1. Int J Pharm. 2022. PMID: 35367584 Review.
The search of alternatives with preferably less reservations concerning degradation and product quality reducing issues leads, among others, to poloxamer 188 (e.g. Kolliphor P188), a nonionic triblock-copolymer surfactant. This review sums up our current knowledge related …
The search of alternatives with preferably less reservations concerning degradation and product quality reducing issues leads, among others, …
Effects of quinolone and poloxamer otic suspension on rat tympanic membranes.
Dirain CO, Antonelli PJ. Dirain CO, et al. Int J Pediatr Otorhinolaryngol. 2021 Aug;147:110805. doi: 10.1016/j.ijporl.2021.110805. Epub 2021 Jun 24. Int J Pediatr Otorhinolaryngol. 2021. PMID: 34175658
We aimed to evaluate if a single application of 6% quinolone in poloxamer causes TMPs in rats. METHODS: Rats were randomized to 5 groups (10/group), with one ear receiving a single otic instillation of 16% poloxamer 407 or 188 (as found in a commercial otic p …
We aimed to evaluate if a single application of 6% quinolone in poloxamer causes TMPs in rats. METHODS: Rats were randomized to 5
Direct-Write Deposition of Thermogels.
Giannitelli SM, Chiono V, Mozetic P. Giannitelli SM, et al. Methods Mol Biol. 2021;2147:137-142. doi: 10.1007/978-1-0716-0611-7_11. Methods Mol Biol. 2021. PMID: 32840816
Adipose-derived stem cells: From mice to man.
Chan KM, Beveridge J, Webber CA. Chan KM, et al. Muscle Nerve. 2018 Aug;58(2):186-188. doi: 10.1002/mus.26154. Muscle Nerve. 2018. PMID: 29742793 No abstract available.
Cubosomes: an overview.
Garg G, Saraf S, Saraf S. Garg G, et al. Biol Pharm Bull. 2007 Feb;30(2):350-3. doi: 10.1248/bpb.30.350. Biol Pharm Bull. 2007. PMID: 17268078 Free article. Review.
[Bone-targeted ultradeformable nanoliposomes].
Guo J, Zhang M, Li YF, Zhen P, Hu X. Guo J, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Apr 18;41(2):203-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19377631 Free article. Chinese.
OBJECTIVE: To study the change in vivo distribution change of ultradeformable nanoliposomes (UL) after being modified by poloxamer 407 (P407), Ethylenediaminetetramethylene phosphonic acid (EDTMP) and 1,12-dodecanediaminetetramethylene phosphonic acid (12-DTM …
OBJECTIVE: To study the change in vivo distribution change of ultradeformable nanoliposomes (UL) after being modified by poloxamer 40 …
Sublingual insulin administration: application of hydroxypropyl beta-cyclodextrin and poloxamer188 as permeation enhancers.
Paprikar A, Soni A, Kaushal N, Lin S. Paprikar A, et al. Pharm Dev Technol. 2021 Feb;26(2):233-242. doi: 10.1080/10837450.2020.1858319. Epub 2020 Dec 14. Pharm Dev Technol. 2021. PMID: 33258391
Cumulative amounts of insulin permeated at 60 min formulated with HPbetaCD (5%), poloxamer 188 (0.5%), and their combination were 1.31, 3.23, and 4.99 IU/cm(2), respectively, indicating an additive effect of combination of HPbetaCD and poloxamer 188. . …
Cumulative amounts of insulin permeated at 60 min formulated with HPbetaCD (5%), poloxamer 188 (0.5%), and their combin …
Prevention of Chlorhexidine Ototoxicity With Poloxamer in Rats.
Dirain CO, Vasquez TK, Antonelli PJ. Dirain CO, et al. Otol Neurotol. 2018 Sep;39(8):e738-e742. doi: 10.1097/MAO.0000000000001920. Otol Neurotol. 2018. PMID: 30113566
No significant hearing loss was observed in ears that were treated with poloxamer and chlorhexidine (-2 to 8 dB) and the results were not different from the ears that received saline, with or without poloxamer (-2.5 to 8 dB and 5-17 dB; p > 0.05). E …
No significant hearing loss was observed in ears that were treated with poloxamer and chlorhexidine (-2 to 8 dB) and the results were …
5,691 results